Ledger.Open graph →
SEC Form D · filed August 5, 2011

Presidio Pharmaceuticals, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
—
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (16)

John F. Obijeski · San Francisco, CADirectorLeo Redmond · San Francisco, CAExecOmar Haffar · San Francisco, CAExec · DirectorDaniel Perez · San Francisco, CADirectorSrinivas Akkaraju · San Francisco, CADirectorFelix Baker · San Francisco, CADirectorKenneth Galbraith · San Francisco, CAExec · DirectorRodney Ferguson · San Francisco, CADirectorBruce C. Long · EDINBURGH, SCOTLAND, United KingdomExec · DirectorJohn G. Barrie · EDINBURGH, SCOTLAND, United KingdomExec · DirectorGeorge W. Browning · EDINBURGH, SCOTLAND, United KingdomExecAlan W. Paterson · EDINBURGH, SCOTLAND, United KingdomDirectorEdward H. Hocknell · EDINBURGH, SCOTLAND, United KingdomDirectorDickson H. Jackson · EDINBURGH, SCOTLAND, United KingdomDirectorNigel N. Cessford · EDINBURGH, SCOTLAND, United KingdomDirectorRon Hunt · East Providence, RIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗